# D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

> **NCT03261284** · NA · UNKNOWN · sponsor: **Wuhan Asia Heart Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Extracorporeal Membrane Oxygenation Complication
- Thrombosis
- Hemorrhage
- Heparin Overdose

## Interventions

- **DIAGNOSTIC_TEST:** D-dimer-guided adjustment stratege
- **DIAGNOSTIC_TEST:** Thepeautic-heparin therapy

## Key facts

- **NCT ID:** NCT03261284
- **Lead sponsor:** Wuhan Asia Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03261284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03261284, "D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03261284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*